These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
332 related articles for article (PubMed ID: 7692048)
21. Electrophysiological studies with new CCK analogs: correlation with binding affinity on B-type receptors. Böhme GA; Durieux C; Stutzmann JM; Charpentier B; Roques BP; Blanchard JC Peptides; 1989; 10(2):407-14. PubMed ID: 2755879 [TBL] [Abstract][Full Text] [Related]
22. Bicarbonate and fluid secretion evoked by cholecystokinin, bombesin and acetylcholine in isolated guinea-pig pancreatic ducts. Szalmay G; Varga G; Kajiyama F; Yang XS; Lang TF; Case RM; Steward MC J Physiol; 2001 Sep; 535(Pt 3):795-807. PubMed ID: 11559776 [TBL] [Abstract][Full Text] [Related]
23. Synthesis and biological activity of 2-phenylethyl ester analogues of C-terminal heptapeptide of cholecystokinin modified in Trp 30 region. Rolland M; Rodriguez M; Lignon MF; Galas MC; Laur J; Aumelas A; Martinez J Int J Pept Protein Res; 1991 Aug; 38(2):181-92. PubMed ID: 1723720 [TBL] [Abstract][Full Text] [Related]
24. Novel CCK analogues and bombesin: a detailed analysis between phosphoinositide breakdown and high-dose inhibition of pancreatic enzyme secretion in three rodent species. Bianchi BR; Miller TR; Witte DG; Lin CW J Pharmacol Exp Ther; 1994 Feb; 268(2):996-1002. PubMed ID: 7509394 [TBL] [Abstract][Full Text] [Related]
25. Receptor occupation, calcium mobilization, and amylase release in pancreatic acini: effect of CCK-JMV-180. Sato S; Stark HA; Martinez J; Beaven MA; Jensen RT; Gardner JD Am J Physiol; 1989 Aug; 257(2 Pt 1):G202-9. PubMed ID: 2475030 [TBL] [Abstract][Full Text] [Related]
26. Role of endogenous cholecystokinin in the facilitation of mu-mediated antinociception by delta-opioid agonists. Noble F; Smadja C; Roques BP J Pharmacol Exp Ther; 1994 Dec; 271(3):1127-34. PubMed ID: 7996417 [TBL] [Abstract][Full Text] [Related]
27. A71378: a CCK agonist with high potency and selectivity for CCK-A receptors. Lin CW; Holladay MW; Witte DG; Miller TR; Wolfram CA; Bianchi BR; Bennett MJ; Nadzan AM Am J Physiol; 1990 Apr; 258(4 Pt 1):G648-51. PubMed ID: 2333977 [TBL] [Abstract][Full Text] [Related]
28. Are C-terminal octapeptide of cholecystokinin and [Leu11]gastrin-(5-17) different in stimulating acid secretion in isolated rabbit gastric glands? Oiry C; Galleyrand JC; Lima-Leite AC; Fulcrand P; Martinez J Eur J Pharmacol; 1995 Dec; 294(2-3):511-9. PubMed ID: 8750713 [TBL] [Abstract][Full Text] [Related]
29. Synthesis of analogues of the Des-Phe-NH2 C-terminal hexapeptide of cholecystokinin showing gastrin antagonist activity. Laur J; Rodriguez M; Aumelas A; Bali JP; Martinez J Int J Pept Protein Res; 1986 Apr; 27(4):386-93. PubMed ID: 3710694 [TBL] [Abstract][Full Text] [Related]
31. Cholecystokinin (CCK)-induced desensitization of pancreatic enzyme secretion is mediated by low affinity CCK receptors. Menozzi D; Stark HA; Martinez J; Jensen RT; Gardner JD Peptides; 1989; 10(2):337-41. PubMed ID: 2474153 [TBL] [Abstract][Full Text] [Related]
32. CCK-B agonist or antagonist activities of structurally hindered and peptidase-resistant Boc-CCK4 derivatives. Corringer PJ; Weng JH; Ducos B; Durieux C; Boudeau P; Bohme A; Roques BP J Med Chem; 1993 Jan; 36(1):166-72. PubMed ID: 8421283 [TBL] [Abstract][Full Text] [Related]
33. Cholecystokinin peptides stimulate pancreatic secretion by multiple signal transduction pathways. Yoshida H; Tsunoda Y; Owyang C Am J Physiol; 1997 Sep; 273(3 Pt 1):G735-47. PubMed ID: 9316479 [TBL] [Abstract][Full Text] [Related]
34. Synthesis of cyclic analogues of cholecystokinin highly selective for central receptors. Rodriguez M; Amblard M; Galas MC; Lignon MF; Aumelas A; Martinez J Int J Pept Protein Res; 1990 May; 35(5):441-51. PubMed ID: 2376470 [TBL] [Abstract][Full Text] [Related]
35. Development of potent and selective CCK-A receptor agonists from Boc-CCK-4: tetrapeptides containing Lys(N epsilon)-amide residues. Shiosaki K; Lin CW; Kopecka H; Craig RA; Bianchi BR; Miller TR; Witte DG; Stashko M; Nadzan AM J Med Chem; 1992 May; 35(11):2007-14. PubMed ID: 1375964 [TBL] [Abstract][Full Text] [Related]
36. ARL 15849: a selective CCK-A agonist with anorectic activity in the rat and dog. Simmons RD; Kaiser FC; Pierson ME; Rosamond JR Pharmacol Biochem Behav; 1998 Feb; 59(2):439-44. PubMed ID: 9476993 [TBL] [Abstract][Full Text] [Related]
37. Carboxylic acids and tetrazoles as isosteric replacements for sulfate in cholecystokinin analogues. Tilley JW; Danho W; Lovey K; Wagner R; Swistok J; Makofske R; Michalewsky J; Triscari J; Nelson D; Weatherford S J Med Chem; 1991 Mar; 34(3):1125-36. PubMed ID: 2002454 [TBL] [Abstract][Full Text] [Related]
39. Synthesis and some pharmacological properties of Z-Tyr(SO3H)-Met-Gly-Trp-Met-Asp(Phe-NH2)-OH, a 32-beta-aspartyl analogue of cholecystokinin (pancreozymin) 27-33. Martinez J; Winternitz F; Bodanszky M; Gardner JD; Walker MD; Mutt V J Med Chem; 1982 May; 25(5):589-93. PubMed ID: 6177857 [TBL] [Abstract][Full Text] [Related]
40. Synthesis of pseudo-peptide analogues of the C-terminal tetrapeptide of gastrin and evaluation of their biological activity on acid secretion. Rodriguez M; Bali JP; Magous R; Castro B; Martinez J Int J Pept Protein Res; 1986 Mar; 27(3):293-9. PubMed ID: 3011690 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]